Medicofarma Biotech SA (WSE: MDB)
Poland
· Delayed Price · Currency is PLN
0.366
+0.006 (1.67%)
At close: Jan 21, 2025
Medicofarma Biotech Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | - | 0.01 | 0.51 | 0.08 | 0.02 | 0.06 | Upgrade
|
Short-Term Investments | 0 | - | - | - | 0.04 | 0.14 | Upgrade
|
Cash & Short-Term Investments | 0 | 0.01 | 0.51 | 0.08 | 0.06 | 0.2 | Upgrade
|
Cash Growth | -87.45% | -98.97% | 556.50% | 20.91% | -68.00% | -43.48% | Upgrade
|
Accounts Receivable | 0.43 | 0.02 | 0.37 | 1.42 | 0.01 | 0.05 | Upgrade
|
Other Receivables | 2.9 | 2.5 | 1.24 | 0.03 | 0.14 | 0.58 | Upgrade
|
Receivables | 3.34 | 2.51 | 1.61 | 1.45 | 0.15 | 0.63 | Upgrade
|
Inventory | 0 | 0 | 0.14 | 0.56 | 0.14 | 0.34 | Upgrade
|
Prepaid Expenses | - | - | - | - | 0.04 | - | Upgrade
|
Total Current Assets | 3.34 | 2.52 | 2.26 | 2.08 | 0.39 | 1.18 | Upgrade
|
Property, Plant & Equipment | 10.94 | 12.09 | 12.56 | 12.7 | - | 0.03 | Upgrade
|
Long-Term Investments | - | - | - | - | - | 0.06 | Upgrade
|
Other Intangible Assets | 0.11 | 0.15 | 1.54 | 1.98 | - | 0.09 | Upgrade
|
Long-Term Deferred Tax Assets | 0.21 | 0.21 | - | - | - | 0.02 | Upgrade
|
Other Long-Term Assets | - | - | 0.01 | - | 0.01 | 0.01 | Upgrade
|
Total Assets | 14.61 | 14.97 | 16.37 | 16.77 | 0.4 | 1.39 | Upgrade
|
Accounts Payable | - | 1.19 | 1.34 | 1.47 | 0.2 | 0.19 | Upgrade
|
Accrued Expenses | 1.33 | 2.26 | 1.11 | 0.44 | - | 0.01 | Upgrade
|
Short-Term Debt | - | 0 | - | - | 0.39 | 0.2 | Upgrade
|
Current Income Taxes Payable | - | 0.53 | 0.14 | 0.06 | 0.04 | 0.04 | Upgrade
|
Other Current Liabilities | 2.71 | 0.04 | 0.69 | 0.12 | - | 0.26 | Upgrade
|
Total Current Liabilities | 4.04 | 4.02 | 3.28 | 2.08 | 0.62 | 0.7 | Upgrade
|
Long-Term Debt | 1.89 | 1.39 | - | - | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0 | Upgrade
|
Other Long-Term Liabilities | 0.87 | 0.38 | 0.48 | 0.48 | - | - | Upgrade
|
Total Liabilities | 6.8 | 5.8 | 3.76 | 2.56 | 0.62 | 0.7 | Upgrade
|
Common Stock | 6.8 | 6.8 | 6.8 | 6.8 | 0.68 | 0.68 | Upgrade
|
Additional Paid-In Capital | 8.95 | 8.95 | 8.95 | 8.95 | 0.42 | 0.42 | Upgrade
|
Retained Earnings | -7.93 | -6.57 | -3.13 | -1.54 | -1.33 | -0.41 | Upgrade
|
Shareholders' Equity | 7.81 | 9.18 | 12.61 | 14.2 | -0.23 | 0.69 | Upgrade
|
Total Liabilities & Equity | 14.61 | 14.97 | 16.37 | 16.77 | 0.4 | 1.39 | Upgrade
|
Total Debt | 1.89 | 1.39 | - | - | 0.39 | 0.2 | Upgrade
|
Net Cash (Debt) | -1.89 | -1.39 | 0.51 | 0.08 | -0.32 | -0 | Upgrade
|
Net Cash Growth | - | - | 556.50% | - | - | - | Upgrade
|
Net Cash Per Share | -0.03 | -0.02 | 0.01 | 0.00 | -0.05 | -0.00 | Upgrade
|
Filing Date Shares Outstanding | 67.98 | 67.98 | 67.98 | 67.98 | 6.78 | 6.78 | Upgrade
|
Total Common Shares Outstanding | 67.98 | 67.98 | 67.98 | 67.98 | 6.78 | 6.78 | Upgrade
|
Working Capital | -0.7 | -1.5 | -1.01 | -0 | -0.24 | 0.48 | Upgrade
|
Book Value Per Share | 0.11 | 0.13 | 0.19 | 0.21 | -0.03 | 0.10 | Upgrade
|
Tangible Book Value | 7.7 | 9.02 | 11.08 | 12.22 | -0.23 | 0.59 | Upgrade
|
Tangible Book Value Per Share | 0.11 | 0.13 | 0.16 | 0.18 | -0.03 | 0.09 | Upgrade
|
Land | - | 0.52 | 0.52 | 0.52 | - | - | Upgrade
|
Buildings | - | 5.06 | 5.06 | 5.06 | - | 0.26 | Upgrade
|
Machinery | - | 9.01 | 8.11 | 7.34 | - | 0.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.